| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |